FDA panel rejects the use of psychedelic drug MDMA to treat patients with PTSD

FDA panel rejects the use of psychedelic drug MDMA to treat patients with PTSD

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The transcript discusses the use of ecstasy to treat PTSD, highlighting that current evidence does not support its effectiveness or benefits outweighing the risks. It marks the first time the FDA has considered a psychedelic drug for medical use. Despite a setback, the drug could still be approved as the FDA values but is not bound by panel recommendations.

Read more

1 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF